Evolution of the Average Target: Healthcare Realty Trust Incorporated

Evolution of the Target Price: Healthcare Realty Trust Incorporated

Changes in Analyst Recommendations: Healthcare Realty Trust Incorporated

601158c43d.ScPJw1StVtIcvFbEtn_VcXu0cnWDirP1GUCAFNo-1tI.EamipSDPGpwx-D2M8h2_KCKDGz_kxeSHQSGwbpt1laAQoqKkDcMe42vEPQ~d83cbf8dcaa818af641384f43c10c130
Wells Fargo Downgrades Healthcare Realty Trust to Underweight From Equalweight, Trims Price Target to $16 From $17 MT
Analyst recommendations: 3M Company, Aon, Murphy USA, Skyworks, Tesla... Our Logo
Citigroup Adjusts Price Target on Healthcare Realty Trust to $17 From $16, Maintains Neutral Rating MT
Scotiabank Adjusts Price Target on Healthcare Realty Trust to $17 From $16, Maintains Sector Perform Rating MT
Analyst recommendations: American Express, Airbnb, Chipotle, Shell... Our Logo
Wells Fargo Raises Price Target on Healthcare Realty Trust to $17 From $16, Maintains Equalweight Rating MT
Scotiabank Adjusts Price Target on Healthcare Realty Trust to $16 From $15, Maintains Sector Perform Rating MT
Wedbush Lifts Healthcare Realty Trust's PT to $16 From $15, Keeps Neutral Rating MT
Citigroup Cuts Healthcare Realty Trust Price Target to $13 From $17.50, Maintains Neutral Rating MT
JPMorgan Cuts Price Target on Healthcare Realty Trust to $17 From $19, Maintains Overweight Rating MT
Stifel Downgrades Healthcare Realty Trust to Hold Form Buy, Price Target is $15 MT
Wedbush Downgrades Healthcare Realty Trust to Neutral From Outperform, Says Up Against Elevated Investor Scrutiny With Slim Margin for Error in Near-Term; Adjusts PT to $15 From $19 MT
Deutsche Bank Initiates Coverage on Healthcare Realty Trust With Hold Rating, $18 Price Target MT
Wells Fargo Trims Price Target on Healthcare Realty Trust to $16 From $17, Maintains Equalweight Rating MT
BTIG Upgrades Healthcare Realty Trust to Buy From Neutral, Price Target is $17 MT
JPMorgan Upgrades Healthcare Realty Trust to Overweight From Neutral, Price Target is $19 MT
Scotiabank Cuts Healthcare Realty Trust's Price Target to $17 From $19, Maintains Sector Perform Rating MT
Wells Fargo Adjusts Healthcare Realty Trust's Price Target to $17 From $19, Equalweight Rating Kept MT
BMO Capital Cuts Price Target on Healthcare Realty Trust to $17 From $20, Keeps Market Perform Rating MT
Wedbush Starts Healthcare Realty Trust at Outperform With $17 Price Target MT
Citigroup Adjusts Price Target on Healthcare Realty Trust to $17 From $19, Maintains Neutral Rating MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $24 From $25, Maintains Overweight Rating MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $25 From $24, Keeps Overweight Rating MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $24 From $28, Maintains Overweight Rating MT
Credit Suisse Downgrades Healthcare Realty Trust to Neutral From Outperform, Lowers Price Target to $20 From $23 MT
More recommendations

Add to a list
Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+0.26%
-5.60%
-3.44%
- +8.81%
-3.89%
-1.60%
+1.38%
-1.12%
+2.67%
+0.26%
Average -0.23%
Weighted average by Cap. -2.75%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.23USD
Average target price
18.28USD
Spread / Average Target
+0.26%
High Price Target
20.00USD
Spread / Highest target
+9.71%
Low Price Target
16.00USD
Spread / Lowest Target
-12.23%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wells Fargo Securities
Scotiabank
Wedbush
Citigroup
JPMorgan Chase
Stifel Nicolaus
Deutsche Bank Securities
BTIG
BMO Capital
Barclays
Credit Suisse
SMBC Nikko
Raymond James
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. HR Stock
  4. Consensus Healthcare Realty Trust Incorporated
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW